Viewing Study NCT06168734


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2025-12-28 @ 1:30 AM
Study NCT ID: NCT06168734
Status: WITHDRAWN
Last Update Posted: 2025-06-08
First Post: 2023-12-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
Sponsor: Venatorx Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module